Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|August 9, 2002
Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberinHan C Dan, Mei Sun, Lin Yang, et al.
Brain Pathology (Zurich, Switzerland)|November 17, 2009
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factorsKarin Boer, Peter B Crino, Jan A Gorter, et al.
Molecular Genetics and Metabolism|December 20, 2014
Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemiaMark Nellist, Rachel Schot, Marianne Hoogeveen-Westerveld, et al.
Molecular Cell|May 11, 2021
TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulationKatharina Fitzian, Anne Brückner, Laura Brohée, et al.
European Journal of Human Genetics : EJHG|July 14, 2016
Genotype and brain pathology phenotype in children with tuberous sclerosis complexIris E Overwater, Rob Swenker, Emma L van der Ende, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complexLaura S Farach, William T Gibson, Steven P Sparagana, et al.
Human Mutation|August 21, 2012
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Human Mutation|December 26, 2015
Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous SclerosisRosemary Ekong, Mark Nellist, Marianne Hoogeveen-Westerveld, et al.
American Journal of Respiratory Cell and Molecular Biology|November 8, 2024
Enhanced Gαq Signaling in TSC2-Deficient Cells Is Required for Their Neoplastic BehaviorAurélie Tréfier, Nihad Tousson-Abouelazm, Lama Yamani, et al.
Pageof 6